SCHEMBL27168545

SCHEMBL27168545

Nc1cccc(C2=CCOCC2)c1OCC(F)(F)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 3/20 0.36
▸ AAK1 Q2M2I8 1/20 0.35
▸ PDCD1 Q15116 1/20 0.33
▸ CD274 Q9NZQ7 1/20 0.33
▸ SCN5A Q14524 1/20 0.33
▸ DYRK1A Q13627 1/20 0.32
▸ MAPK14 Q16539 4/20 0.32
▸ CSNK1D P48730 2/20 0.32
▸ CSNK1E P49674 2/20 0.32
▸ PIK3CA P42336 3/20 0.31
▸ MTOR P42345 2/20 0.31
▸ PDE8A O60658 1/20 0.31
▸ PIK3CD O00329 1/20 0.31
▸ BACE1 P56817 2/20 0.30
▸ CDC7 O00311 1/20 0.30
▸ CDK2 P24941 1/20 0.30
▸ CTSD P07339 1/20 0.30
▸ IDH2 P48735 1/20 0.30
▸ PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29517013 0.90 AAK1 (0.39) SCN9AAAK1PDCD1CD274DYRK1A
SCHEMBL25217229 0.90 AAK1 (0.39) SCN9AAAK1PDCD1CD274DYRK1A
SCHEMBL26162619 0.81 PDCD1 (0.38) PDCD1CD274MAPK14PIK3CAMTOR
SCHEMBL26162799 0.76 AAK1 (0.37) AAK1PDCD1CD274MAPK14CSNK1D
SCHEMBL27168544 0.76 AAK1 (0.37) AAK1PDCD1CD274MAPK14CSNK1D
SCHEMBL26162658 0.76 PDCD1 (0.35) SCN9APDCD1CD274DYRK1AMAPK14
SCHEMBL26162654 0.74 PDCD1 (0.38) AAK1PDCD1CD274MAPK14CSNK1D
SCHEMBL26162804 0.72 AAK1 (0.38) AAK1PIK3CAMTORIDH2
SCHEMBL26162797 0.72 PIK3CA (0.38) AAK1DYRK1APIK3CAMTORCDC7
SCHEMBL29517002 0.71 IDH2 (0.36) SCN9AAAK1MAPK14PIK3CDIDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421217-B2 Pyrazine derivative or salt thereof, and use of same FUJIFILM CORPORATION (JP) 2025-09-23 — — US disclosed
EP-4052760-B1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME FUJIFILM CORP (JP) 2024-03-13 — — EP disclosed
EP-4052760-A1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME FUJIFILM Corporation (JP) 2022-09-07 — — EP disclosed
US-20220259185-A1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME FUJIFILM CORPORATION (JP) 2022-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12421217-B2 Pyrazine derivative or salt thereof, and use of same DHODH, IDH1, IDH2 SCN9A 3158/4885AAK1 3745/4885PDCD1 633/4885
US-20220259185-A1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME DHODH, IDH1, IDH2 SCN9A 3158/4885AAK1 3745/4885PDCD1 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback